• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Fluid/Blood Leak (1250); Gradient Increase (1270); Difficult to Open or Close (2921); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis/Thrombus (4440); Heart Failure/Congestive Heart Failure (4446)
Event Date 05/28/2022
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: the device was not returned for evaluation as it was discarded by the customer.Two pictures of the explanted valve were sent and reviewed.As per image evaluation, customer report of gradient increase and leaflet thickening was unable to be confirmed through image evaluation.Customer report of thrombus was confirmed through evaluation of the images provided.Pictures showed the outflow aspect of an explanted valve.What appeared to be vegetation was visible on the leaflets.Sewing ring was observed to be cut off around the valve.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification that an inspiris resilia valve model 11500a25 was explanted after an implant duration of eight (8) months and twenty three (23) days due to valve thrombosis and leaflet thickening limiting the opening surface with gradient increase at 55 mmhg (mean gradient post operatively was 14 mmhg) and moderate regurgitation, with no signs of vegetation or abscess.Endocarditis was ruled out through multiple blood culture and serology which all resulted negative.The patient presented with nyha ii-iii dyspnea.An inspiris resilia valve model 11500a27 was implanted in replacement with no post operative complications except episode of flutter.Seven (7) months and twenty three (23) days after this avr the patient underwent a valve-in-valve procedure due to stenosis and regurgitation caused by a second valve thrombosis [medwatch #25507].
 
Manufacturer Narrative
Updated d4 (device expiration date) and h4 (device manufacturer date).Updated section b4 (date of this report), g3 (date received by manufacturer), h6 (health effect - clinical code), h6 (type of investigation), h6 (investigation findings) and h6 (investigations conclusions).Corrected h6 (type of investigation), included "device discarded" instead of "device not accessible for testing" h10: additional manufacturer narrative: the device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Valve thrombosis is the formation of significant blood clots forming on the valve/ring.These clots could significantly impact the functionality of the valve resulting in heart failure or thromboembolism.In this case, the most likely cause is patient factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 office m2013
irvine, CA 92614
9492506615
MDR Report Key16276614
MDR Text Key308526010
Report Number2015691-2023-10473
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/10/2023
Initial Date FDA Received02/01/2023
Supplement Dates Manufacturer Received03/03/2023
Supplement Dates FDA Received03/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age66 YR
Patient SexMale
Patient Weight95 KG
-
-